Covid-19: Zydus Cadila’s vaccine found safe in early-stage human trial, Phase II to commence today
Scroll.in Date: Aug 07, 2020 letters@scroll.in, Pharmaceutical company Zydus Cadila on Wednesday said its coronavirus vaccine candidate was found to be safe, immunogenic, and well-tolerated in an early-stage human trial. In a regulatory filing, the firm said it will start Phase II trials in over 1,000 healthy adult volunteers from Thursday to test its effectiveness against the infection. “The Phase I dosing to establish the safety of ZyCoV-D is an important milestone,” Zydus Cadila chairperson Pankaj R Patel said. “All the subjects in Phase I clinical trial were closely monitored in a clinical pharmacological unit for 24 hours post dosing for safety and for 7 days thereafter and vaccine was found to be very safe. We now begin the Phase II clinical trials and look forward to evaluating the safety and immunogenicity of the vaccine in a larger population.” The seven-day safety of the vaccine candidate in volunteers enrolled in the Phase I trial, who were administered doses since July...